Level C· Early human research exploring benefitsProspective StudyPubMed

Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface.

Hsueh YY., Chiang YL., Wu CC., Lin SC.

Prospective Study on Spinal Cord Injury, Neuroinflammation, published in Cells Tissues Organs (2012) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Cells Tissues Organs (2012)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
22327282
DOI
10.1159/000332045
Citations
23

Abstract (original English)

The application of stem cells appears to have great therapeutic potential to facilitate nerve regeneration in patients with neurodegenerative disease or spinal cord injury. Human adipose-derived stem cells (hADSCs), a subset of multipotent mesenchymal stem cells, possess the great advantages of an abundant amount of cells, less ethical conflict and minimal invasive surgical procedures to obtain the cells. Chitosan, a naturally derived polysaccharide from chitin, has been widely studied to facilitate and guide the direction of nerve regeneration as a biomaterial for the neural tube. Chitosan also serves as a three-dimensional culture substrate to facilitate cellular sphere formation among various cells but is as yet unexplored in hADSCs. In this study, the ability of hADSCs to transdifferentiate from the mesenchymal into the neural lineage by seeding hADSCs on a chitosan-coated surface to form therapeutic cell spheres was investigated. The optimal seeding density (2 × 10(4) cells/cm(2)) and harvesting time (72 h) to obtain sphere formation were determined by cell viability on a chitosan-coated surface. Expression of neural lineage markers was observed by immunofluorescent staining of nestin, neurofilament heavy chain and glial fibrillary acidic protein. The neural induction potentials were also provoked by replating spheres from primary to tertiary passages. The effect of neural

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdipocytesAdipose TissueCell DifferentiationChitosanHumansMultipotent Stem CellsNeural Stem CellsNeuronsSpheroids, CellularStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research